FIELD: medicine. SUBSTANCE: method involves studying beta-adrenoreception values of cell membranes as diagnosis criterion at the treatment start and 7 days later after the therapy is over. The value being from 10 to 40 units, positive treatment action is to be predicted. EFFECT: revealed individual sensitivity to pharmacotherapy; high reliability in predicting its efficiency. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING EFFICIENCY OF β-ADRENOBLOCKERS AT ARTERIAL HYPERTENSION | 2002 |
|
RU2237246C2 |
| METHOD FOR PREDICTION OF ENDOTHELIAL FUNCTION CONDITION IN ANTIHYPERTENSIVE THERAPY | 2009 |
|
RU2406436C1 |
| METHOD OF PREDICTING LUNG CANCER ARISING IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE | 2009 |
|
RU2407013C1 |
| METHOD FOR PREDICTING THE PROGRESSION OF CHRONIC CARDIAC FAILURE WITHIN A YEAR AFTER A PREVIOUS MYOCARDIAL INFARCTION | 2019 |
|
RU2716749C1 |
| METHOD FOR PREDICTION OF PROGRESSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | 2015 |
|
RU2599349C1 |
| METHOD FOR RECOVERY TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASES | 2001 |
|
RU2211688C2 |
| METHOD OF TREATING PATIENTS WITH BRONCHIAL ASTHMA | 2008 |
|
RU2383345C1 |
| METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY TO BETA-ADRENOCEPTOR BLOCKERS IN ARTERIAL HYPERTENSION CASES | 2003 |
|
RU2265846C2 |
| METHOD FOR ASSESSING RISK OF DEVELOPING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2013 |
|
RU2545740C1 |
| METHOD AND AGENT FOR PREVENTING INTRA- AND POSTOPERATIVE COMPLICATIONS IN PATIENT WITH LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2014 |
|
RU2568878C1 |
